Sort by
Refine Your Search
-
Country
-
Employer
-
Field
-
target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead
-
Performance Plan with a bonus target of 15.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help
-
expertise in cell cycle or/and cell signaling to develop innovative strategies for understanding the role of cell cycle or cell signaling in cancer progression, drug resistance and immune modulation Design
-
for participation in Pfizer's Global Performance Plan with a bonus target of 12.5% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous
-
the pharmaceutical or biotechnology industry, with at least 8 years of the experience specifically in project/program management. If in possession of a PhD/PharmD, have a minimum of 9 years' experience, in
-
years' experience, in the pharmaceutical or biotechnology industry, with at least 8 years of the experience specifically in project/program management. If in possession of a PhD/PharmD, have a minimum of
-
full alignment with the other CMC and associated functions (Drug Product Design, Clinical and Commercial Supply Chains, Nonclinical and Clinical Development, Quality Assurance, Regulatory Affairs, Pfizer
-
research data infrastructure: Cooperate closely with the Federal Ministry of Health and other federal authorities within its remit, in particular the Health Data lab at the Federal Institute for Drugs and
-
, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We
-
Research will develop a disease specific global network of potential investigators and key opinion leaders (KoL) for the new therapeutic before PoM, SoCA or POC trial conception to assist in trial design, as